Interferon beta biobetter(Abion)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon beta biobetter(Abion)
Drug Alias NameABN-101
ClassificationBiologics
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbion Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbion Inc
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A